Details

NameSymbolSector
PFIZER LTD.PFIZERPharmaceuticals
Open
4530
High
4580.8
Low
4300
Close
4310.7
Volume
186580
Exchange
nse
Time
08-Sep-2026

Outlook

Score:  

0.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Pfizer is  
Closing Marubozu
Estimated Stoploss of Pfizer is ₹  
4580.8
Pfizer has a  
Bearishℹ
 pattern. 
Formation of  
Closing Marubozu
 candle pattern indicates Pfizer has chances of  
Continuationℹ
 of the current trend. 

Trend

Pfizer is in  
Downtrendℹ
. 
Price of Pfizer is  
Downℹ
 by  

8.07

%. 
Target
Buy @ 

4300

Sell @ 

4610

Current @ 

4310.7

Volume

The trades of Pfizer have been in  
Immenseℹ
 volume. 
The volume trades for Pfizer are  
Bearishℹ
 with  
Strong Sellersℹ
The trade volume of Pfizer is  

Up

 by  

322.91

% 

Valuation

The current market price of Pfizer is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 4911cr and total assets worth ₹ 4911cr, the balance sheet of Pfizer is:  
Balancedℹ
. 
Cashflow
Pfizer has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 383cr

. It is  
Upℹ
 by  

410.67

%. 

(*Mar 2025)

70.48% i.e. ₹ 659cr earned in operatingℹ
7.59% i.e. ₹ 71cr spent in investingℹ
21.93% i.e. ₹ 205cr spent in financingℹ
0% in otherℹ
Pfizer has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 75cr

. It is  
Upℹ
 by  

388.46

%. 

(*Mar 2024)

47.06% i.e. ₹ 256cr earned in operatingℹ
9.74% i.e. ₹ 53cr earned in investingℹ
43.2% i.e. ₹ 235cr spent in financingℹ
0% in otherℹ
Income
The income of Pfizer is  

₹ 684cr

 and  

Profit

 is :  

₹ 189cr

(*Sep 2025)

Pfizer Profit is down by:  

1.05

% and Income is Up by:  

2.09

% 

(*Sep 2025)

The income of Pfizer is  

₹ 670cr

 and  

Profit

 is :  

₹ 191cr

(*Jun 2025)

Pfizer Profit is down by:  

42.12

% and Income is Up by:  

5.35

% 

(*Jun 2025)

The income of Pfizer is  

₹ 636cr

 and  

Profit

 is :  

₹ 330cr

(*Mar 2025)

Pfizer Profit is up by:  

159.84

% and Income is Up by:  

9.66

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.